Compugen Ltd (CGEN)

Apr 02, 2025

Compugen at AI Drug Discovery Conference: Strategic Partnerships Drive Progress - Investing.com

Apr 02, 2025

Mar 26, 2025

Cancer AI Breakthrough: Compugen Takes Center Stage at 3 Elite Healthcare Forums - Stock Titan

Mar 26, 2025

Mar 26, 2025

Compugen to Participate in Multiple Virtual Investor Conferences in April 2025 - Yahoo Finance

Mar 26, 2025

Mar 23, 2025

Compugen Ltd. (CGEN): Among the Penny Stocks With Huge Upside Potential According to Analysts - MSN

Mar 23, 2025

Mar 23, 2025

Compugen Ltd. (NASDAQ:CGEN) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - Defense World

Mar 23, 2025

Mar 21, 2025

Reviewing Aligos Therapeutics (NASDAQ:ALGS) and Compugen (NASDAQ:CGEN) - Armenian Reporter

Mar 21, 2025

Mar 12, 2025

Compugen at Leerink’s Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 10, 2025

Oppenheimer & Co. Inc. Raises Stock Position in Compugen Ltd. (NASDAQ:CGEN) - Defense World

Mar 10, 2025

Mar 09, 2025

Earnings call transcript: Compugen Q4 2024 reveals revenue decline By Investing.com - Investing.com Australia

Mar 09, 2025

Mar 07, 2025

Compugen Ltd. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 07, 2025

Compugen (NASDAQ:CGEN) Rating Lowered to Hold at StockNews.com - Defense World

Mar 07, 2025

Mar 05, 2025

Rodman & Renshaw maintains $4 price target on Compugen stock By Investing.com - Investing.com Australia

Mar 05, 2025

Mar 05, 2025

Compugen Ltd. (NASDAQ:CGEN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 05, 2025

Mar 05, 2025

Compugen Ltd (CGEN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus.com

Mar 05, 2025

Mar 04, 2025

Compugen’s 2024 Results Highlight Clinical Progress and Financial Stability - TipRanks

Mar 04, 2025

Mar 04, 2025

Earnings call transcript: Compugen Q4 2024 reveals revenue decline - Investing.com India

Mar 04, 2025

Mar 04, 2025

Rodman & Renshaw maintains $4 price target on Compugen stock - Investing.com India

Mar 04, 2025

Mar 04, 2025

Compugen Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 04, 2025

Mar 04, 2025

Compugen (CGEN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 04, 2025

Mar 04, 2025

Compugen: Q4 Earnings Snapshot - CTPost

Mar 04, 2025

Mar 04, 2025

Compugen earnings missed by $0.09, revenue fell short of estimates - Investing.com South Africa

Mar 04, 2025

Mar 04, 2025

Compugen Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 04, 2025

Mar 04, 2025

Compugen: Q4 Earnings Snapshot -March 04, 2025 at 07:23 am EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Compugen Reports Fourth Quarter and Full Year 2024 Results -March 04, 2025 at 07:13 am EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Compugen reports Q4 EPS (7c) vs. 11c last year - TipRanks

Mar 04, 2025

Mar 04, 2025

Earnings Flash (CGEN) COMPUGEN LTD. Posts Q4 Loss $-0.07 Per Share -March 04, 2025 at 07:08 am EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Earnings Flash (CW9) COMPUGEN LTD. Posts Q4 Revenue $1.5M - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Earnings Flash (CGEN) COMPUGEN LTD. Posts Q4 Revenue $1.5M -March 04, 2025 at 07:09 am EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

How Compugen's Cancer Immunotherapy Pipeline Is Advancing While Extending Cash Runway to 2027 - StockTitan

Mar 04, 2025

Mar 03, 2025

Cancer Immunotherapy Pioneer Compugen to Share Insights at Major Healthcare Conference - StockTitan

Mar 03, 2025

Mar 03, 2025

Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global Healthcare Conference - Yahoo Finance

Mar 03, 2025

Mar 02, 2025

Compugen (CGEN) Projected to Post Quarterly Earnings on Tuesday - Defense World

Mar 02, 2025

Feb 28, 2025

Compugen Ltd expected to post earnings of 7 cents a shareEarnings Preview - TradingView

Feb 28, 2025

Feb 27, 2025

Compugen (CGEN) Expected to Announce Earnings on Tuesday - MarketBeat

Feb 27, 2025

Feb 26, 2025

Improved Revenues Required Before Compugen Ltd. (NASDAQ:CGEN) Shares Find Their Feet - Simply Wall St

Feb 26, 2025

Feb 26, 2025

How Compugen's AI Platform Partnership Could Revolutionize Cancer Immunotherapy Discovery - StockTitan

Feb 26, 2025

Feb 25, 2025

Compugen Ltd. Enhances its AI/ML Predictive Computational Discovery Platform, Unigen?? with Ultima Genomics' Single Cell Genomics Sequencing Technology - Marketscreener.com

Feb 25, 2025

Feb 20, 2025

Compugen Ltd. Sets Date for Q4 2024 Financial Results Announcement - TipRanks

Feb 20, 2025

Feb 18, 2025

Earnings Alert: Compugen Sets Date for Critical Year-End Financial Report & Strategic Update - StockTitan

Feb 18, 2025

Feb 18, 2025

Compugen: Immuno-Oncology Innovator Poised For A Comeback (NASDAQ:CGEN) - Seeking Alpha

Feb 18, 2025

Feb 18, 2025

Compugen (NASDAQ:CGEN) Shares Cross Above 200-Day Moving Average – Time to Sell? - Defense World

Feb 18, 2025

Feb 18, 2025

Compugen Announces Significant Share Price Increase - TipRanks

Feb 18, 2025

Feb 15, 2025

Compugen Updates Filing Structure with Bristol Myers Squibb - TipRanks

Feb 15, 2025

Feb 13, 2025

Computational Biology Market to Generate $9.52 Billion in Revenues in 2025; Forecast to Reach $22.47 Billion by 2029Analysis of the Key Drivers, Top Segments, Regional Shifts, Leading Players & More - Yahoo Finance

Feb 13, 2025

Feb 13, 2025

Financial Comparison: Compugen (NASDAQ:CGEN) & Artiva Biotherapeutics (NASDAQ:ARTV) - Defense World

Feb 13, 2025

Feb 11, 2025

CGEN’s Q2 earnings predictions: What the experts say - US Post News

Feb 11, 2025

Feb 08, 2025

Compugen Ltd (NASDAQ: CGEN) Has Decreased By 14.22 Percent This Year. Is It A Better Buy Than Others? - Marketing Sentinel

Feb 08, 2025

Feb 06, 2025

JPMorgan Chase & Co. Has $122,000 Stock Holdings in Compugen Ltd. (NASDAQ:CGEN) - MarketBeat

Feb 06, 2025

Feb 06, 2025

Views of Wall Street’s Leading Experts on Compugen Ltd - SETE News

Feb 06, 2025

Feb 06, 2025

The Psychology of Compugen Ltd Inc. (CGEN) Price Performance: Understanding Market Sentiment - The InvestChronicle

Feb 06, 2025